This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David S. Cooper, MD; Alan J. Gelenberg, MD; Joanne C. Wojcik; Velia C. Saxe; E. Chester Ridgway, MD; Farahe Maloof, MD

Arch Intern Med. 1981;141(8):1023-1025.

Abstract
• The effect of traditional tricyclic antidepressants on serum prolactin levels is controversial. In a five-week double-blind study of depressed outpatients, imipramine hydrochloride therapy did not lead to any significant change in serum prolactin levels. In contrast, amoxapine, a new antidepressant, produced significant elevations in serum prolactin levels in female and in male patients. Amoxapine may block dopamine receptors in central tuberoinfundibular pathways, which would account for its prolactin-elevating activity. On the other hand, imipramine and other traditional tricyclic antidepressants do not affect dopamine transmission, do not raise serum prolactin levels, and are not effective antipsychotic drugs.

(Arch Intern Med 1981;141:1023-1025)

Author Affiliations
From the Thyroid Unit of the Department of Medicine (Drs Cooper, Ridgway, and Maloof and Ms Saxe) and the Department of Psychiatry (Dr Gelenberg and Ms Wojcik), Massachusetts General Hospital, Boston.

Footnotes
Accepted for publication June 13, 1980.

Reprint requests to Thyroid Unit, Massachusetts General Hospital, Boston, MA 02114 (Dr Cooper).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?